A prognostic nomogram for predicting breast cancer survival based on mammography and AJCC staging
- PMID: 38449621
- PMCID: PMC10915383
- DOI: 10.1016/j.heliyon.2024.e27072
A prognostic nomogram for predicting breast cancer survival based on mammography and AJCC staging
Abstract
Rationale and objectives: To develop a prognostic nomogram using mammography data and AJCC staging to predict breast cancer survival.
Materials and methods: A prognostic nomogram was created using data from 1000 women diagnosed with breast cancer at a medical cancer center in Taiwan between 2011 and 2015. The variables included age at diagnosis (≤60 or > 60 years), mammography purpose (screening or diagnostic), mammography modality (digital mammogram or digital breast tomosynthesis), and the 7th American Joint Committee on Cancer (AJCC) stage. The outcome predicted was breast cancer-related mortality. The nomogram utilized Kaplan-Meier analysis for all subsets and Cox proportional hazards regression analysis for prediction. The nomogram's accuracy was internally validated using the concordance index and receiver operating characteristic (ROC) curve analysis, focusing on 3-year and 5-year survival predictions.
Results: Participants' mean age at breast cancer diagnosis was 54 years (SD = 11.2 years). The 1-year, 3-year, and 5-year overall survival (OS) rates were found to be 99.7%, 95.3%, and 91.4%, respectively. The bootstrap-corrected concordance indices indicated the following: nomogram, 0.807 and AJCC, 0.759. A significant difference was observed between the nomogram's area under the curve (AUC) and the AJCC stage in predicting the probability of 5-year survival (p = 0.005). A nomogram, constructed based on mammography and AJCC, demonstrated excellent calibration through internal validation using bootstrapping.
Conclusion: The utilization of a nomogram that incorporates mammography data and the AJCC registry data has been demonstrated to be a reliable predictor of breast cancer survival.
Keywords: AJCC staging; Breast cancer; Breast cancer survival; Mammography; Nomogram.
© 2024 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures





Similar articles
-
Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.Bosn J Basic Med Sci. 2021 Oct 1;21(5):632-641. doi: 10.17305/bjbms.2020.5420. Bosn J Basic Med Sci. 2021. PMID: 33577444 Free PMC article.
-
Development and Validation of a Nomogram for Predicting Survival in Male Patients With Breast Cancer.Front Oncol. 2019 May 14;9:361. doi: 10.3389/fonc.2019.00361. eCollection 2019. Front Oncol. 2019. PMID: 31139562 Free PMC article.
-
Risk stratification system and web-based nomogram constructed for predicting the overall survival of primary osteosarcoma patients after surgical resection.Front Public Health. 2022 Aug 5;10:949500. doi: 10.3389/fpubh.2022.949500. eCollection 2022. Front Public Health. 2022. PMID: 35991065 Free PMC article.
-
Nomograms for Predicting Cancer-Specific Survival of Patients with Gingiva Squamous Cell Carcinoma: A Population-Based Study.Curr Med Sci. 2021 Oct;41(5):953-960. doi: 10.1007/s11596-021-2435-x. Epub 2021 Oct 25. Curr Med Sci. 2021. PMID: 34693495
-
Development and validation of a prognostic nomogram for breast cancer patients who underwent chemoradiotherapy and surgery: a retrospective cohort study based on the SEER database and two Chinese cohorts.Am J Cancer Res. 2023 Nov 15;13(11):5065-5081. eCollection 2023. Am J Cancer Res. 2023. PMID: 38058820 Free PMC article.
Cited by
-
Personalized predictions of neoadjuvant chemotherapy response in breast cancer using machine learning and full-field digital mammography radiomics.Front Med (Lausanne). 2025 Apr 17;12:1582560. doi: 10.3389/fmed.2025.1582560. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40313551 Free PMC article.
References
-
- Duffy S.W., Tabar L., Yen A.M., Dean P.B., Smith R.A., Jonsson H., Tornberg S., Chen S.L., Chiu S.Y., Fann J.C., Ku M.M., Wu W.Y., Hsu C.Y., Chen Y.C., Svane G., Azavedo E., Grundstrom H., Sunden P., Leifland K., Frodis E., Ramos J., Epstein B., Akerlund A., Sundbom A., Bordas P., Wallin H., Starck L., Bjorkgren A., Carlson S., Fredriksson I., Ahlgren J., Ohman D., Holmberg L., Chen T.H. Mammography screening reduces rates of advanced and fatal breast cancers: results in 549,091 women. Cancer. 2020;126(13):2971–2979. - PMC - PubMed
-
- Wu S.G., Wang J., Lian C.L., Lei J., Hua L., Lin Q., Chen Y.X., He Z.Y. Evaluation of the 8th edition of the American joint committee on cancer's pathological staging system in prognosis assessment and treatment decision making for stage T1-2N1 breast cancer after mastectomy. Breast. 2020;51:2–10. - PMC - PubMed
LinkOut - more resources
Full Text Sources